A recent study reveals that patients who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt conventional lifestyle plans.
Published data in a prominent medical journal shows that while obese people frequently drop a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these drugs need to be cognizant of the danger of rapid rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to starting weight in about 18 months.
Analyzing Approaches
The study, which reviewed 37 of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.
Researchers point out that people who lose weight through dieting typically have a more gradual creep back—around 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Experts propose the mechanism of the injections accounts for the accelerated regain.
These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating far more likely."
A Lifelong Issue?
Health authorities recommend the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, due to the significant potential of relapse, the treatment is often life-long.
This opinion is supported by drug manufacturers, who state that the results "underscore the long-term nature of obesity," comparing it to managing conditions like hypertension.
User Testimonies
Individuals who have stopped the medication explain a sudden return of appetite.
"It felt as if a switch activating and you're instantly extremely hungry," described one woman.
This challenge is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment.
Widespread Adoption
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Use is more common among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic solution and maintained weight loss hinges on integrated lifestyle changes.
